157 related articles for article (PubMed ID: 36972796)
21. Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes.
Burchill MA; Salomon MP; Golden-Mason L; Wieland A; Maretti-Mira AC; Gale M; Rosen HR
PLoS Pathog; 2021 Aug; 17(8):e1009799. PubMed ID: 34370798
[TBL] [Abstract][Full Text] [Related]
22. High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease.
Hedegaard DL; Tully DC; Rowe IA; Reynolds GM; Bean DJ; Hu K; Davis C; Wilhelm A; Ogilvie CB; Power KA; Tarr AW; Kelly D; Allen TM; Balfe P; McKeating JA
J Hepatol; 2017 Jan; 66(1):28-38. PubMed ID: 27531641
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C viral RNA in blood mononuclear cells of patients treated with directly acting antivirals.
Kamhawy A; Ahmed Said ZN; Abdelhamid SE; El-Sayed M; Eletreby R; Garem HE; El Kassas M; Esmat G
Arab J Gastroenterol; 2021 Jun; 22(2):158-163. PubMed ID: 33820724
[TBL] [Abstract][Full Text] [Related]
24. High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study.
Mancuso ME; Linari S; Santagostino E; Bartolozzi D; D'Ambrosio R; Borghi M; Lampertico P; Peyvandi F; Castaman G; Aghemo A
Liver Int; 2020 May; 40(5):1062-1068. PubMed ID: 31876354
[TBL] [Abstract][Full Text] [Related]
25. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.
Manickam C; Rajakumar P; Wachtman L; Kramer JA; Martinot AJ; Varner V; Giavedoni LD; Reeves RK
J Virol; 2016 Oct; 90(20):9153-62. PubMed ID: 27489267
[TBL] [Abstract][Full Text] [Related]
26. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
Herderschee J; Heinonen T; Fenwick C; Schrijver IT; Ohmiti K; Moradpour D; Cavassini M; Pantaleo G; Roger T; Calandra T;
Clin Microbiol Infect; 2022 Apr; 28(4):611.e1-611.e7. PubMed ID: 34474121
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection.
Pham TN; King D; Macparland SA; McGrath JS; Reddy SB; Bursey FR; Michalak TI
Gastroenterology; 2008 Mar; 134(3):812-22. PubMed ID: 18243182
[TBL] [Abstract][Full Text] [Related]
28. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
29. Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality.
Wang Y; Rao H; Chi X; Li B; Liu H; Wu L; Zhang H; Liu S; Zhou G; Li N; Niu J; Wei L; Zhao J
EBioMedicine; 2019 Aug; 46():227-235. PubMed ID: 31345785
[TBL] [Abstract][Full Text] [Related]
30. Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus.
Sachithanandham J; Balagopal A; Leep-Lazar J; Quinn J; Bowden K; Ward K; Ribeiro RM; Sulkowski MS
J Infect Dis; 2023 Aug; 228(3):311-320. PubMed ID: 36722133
[TBL] [Abstract][Full Text] [Related]
31. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
32. Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.
Hyrina A; Olmstead AD; Steven P; Krajden M; Tam E; Jean F
EBioMedicine; 2017 Sep; 23():68-78. PubMed ID: 28864162
[TBL] [Abstract][Full Text] [Related]
33. Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection.
Auma AWN; Shive CL; Kostadinova L; Anthony DD
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062255
[TBL] [Abstract][Full Text] [Related]
34. Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report.
Aldunate F; Echeverría N; Chiodi D; López P; Sánchez-Cicerón A; Soñora M; Cristina J; Moratorio G; Hernández N; Moreno P
BMC Infect Dis; 2021 Apr; 21(1):387. PubMed ID: 33902462
[TBL] [Abstract][Full Text] [Related]
35. T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.
Callendret B; Eccleston HB; Hall S; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
Hepatology; 2014 Nov; 60(5):1531-40. PubMed ID: 24975498
[TBL] [Abstract][Full Text] [Related]
36. Modulation of Memory B Cell Phenotypes and Toll-Like Receptor-7 in Chronic Hepatitis C Virus Infection During Direct-Acting Antiviral Interferon-Free Therapy: Correlation with Interleukin-7.
Moustafa H; Madkour M; Hamed F; Abouelnazar S; Abo Elwafa R; Moaaz M
Viral Immunol; 2021 May; 34(4):227-240. PubMed ID: 33180667
[TBL] [Abstract][Full Text] [Related]
37. Acute myeloid leukaemia following direct acting antiviral drugs in HCV-infected patients: A 10 years' retrospective single-center study.
Scheifer C; Luckina E; Lebrun-Vignes B; Diop AA; Damais-Thabut D; Roos-Weil D; Dechartres A; Lebray P
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):102000. PubMed ID: 35933093
[TBL] [Abstract][Full Text] [Related]
38. Direct-acting antivirals for chronic hepatitis C.
Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012143. PubMed ID: 28922704
[TBL] [Abstract][Full Text] [Related]
39. Enhanced immune responses, PI3K/AKT and JAK/STAT signaling pathways following hepatitis C virus eradication by direct-acting antiviral therapy among Egyptian patients: a case control study.
Ramadan HK; Badr G; Ramadan NK; Sayed A
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33524139
[TBL] [Abstract][Full Text] [Related]
40. Quality improvement to evaluate and provide treatment for chronic hepatitis C postpartum.
Behnke C; Nissim O; Simerlein W; Beeker K; Tarleton JL; Lazenby GB
J Am Pharm Assoc (2003); 2022; 62(3):864-869. PubMed ID: 34975005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
